Identification and management of the woman at increased risk for breast cancer development

Lynch H, Guingis M, Brodkey F, Lynch J: Genetic heterogeneity and familial carcinoma of the breast. Surg Gynecol Obstet 142: 693–699, 1976 Newman B, Austin MA, Lee M, King MC: Inheritance of human breast cancer: evidence for autosomal dominant transmission in high risk families. Proc Natl Acad Sci (USA) 85: 3044–3048, 1988 Sideransky D, Tokino T, Helzlsoner K, Zehnbauer B, Rausch G, Shelton B, Prestigiacomo L: Inherited P53 gene mutations in breast cancer. Cancer Res 52: 2984–2986, 1992 Coles C, Condie A, Chetty U, Steele CM, Evans HJ, Prosser J: P53 mutations in breast cancer. Cancer Res 52: 5291–5298, 1992 Hall JM, Lee MK, Morrow J, Anderson LA, Huey B, King MC: Linkage of early onset familial breast cancer to chromosome 17q21. Science 250: 1684–1689, 1990 King MC: Breast cancer genes: how many, where, and who are they? Nature Genet 2: 80–90, 1992 King MC, Rowell S, Love S: Inherited breast and ovarian cancer. What are the risks? What are the choices? JAMA 269: 1975–1980, 1993 Ottman R, King MC, Pike M, Henderson B: Practical guide for estimating risk for familial breast cancer. Lancet 2: 556–558, 1983 Schwartz AG, King MC, Belle S, Satariano WA, Swanson GM: Risk of breast cancer to relatives of young breast cancer patients. J Natl Cancer Inst 75: 665–668, 1985 Anderson D, Badzioch M: Bilaterality in familial breast cancer patients. Cancer 56: 2092–2098, 1985 MacMahon B, Cole P, Brown J: Etiology of human breast cancer: A review. J Natl Cancer Inst 50: 21–42, 1973 Henderson B, Ross R, Ludd H: Do regular ovulatory cycles increase breast cancer risk? Cancer 56: 1206–1208, 1985 Bernstein L, Ross R, Lobo Ret al.: The effects of moderate physical activity on menstrual cycle patterns in adolescence: implications for breast cancer prevention. Br J Cancer 55: 681–685, 1987 Thomas D, Lilienfeld A: Geographic, reproductive, and sociobiological factors. In: Stoll B (ed) Risk Factors in Breast Cancer. Wm. Heinemann Medical Books, Chicago, 1976, p25 Trichopoulous D, MacMahon B, Cole P: Menopause and breast cancer risk. J Natl Cancer Inst 48: 605–613, 1972 MacMahon B, Cole P, Lin T, Lowe CR, Mirra AP, Ravnihar B, Solber EJ, Valgoras VG, Yuosa S: Age at first birth and breast cancer risk. Bull WH0 43: 209–221, 1970 Trichopoulous P, Hsieh C, MacMahon B, Lin T, Lowe CR, Mirra AP, Ravnihar B, Solber EJ, Valaoras VG, Yuosa S: Age at any birth and breast cancer risk. Int J Cancer 31: 701–704, 1983 Brinton L, Hoover R, Fraumeni J: Reproductive factors in etiology of breast cancer. Br J Cancer 47: 757–762, 1983 Pike M, Henderson B, Casagrande J, Rosario I, Grey GE: Oral contraceptive use and early abortion as risk factors for breast cancer in young women. Br J Cancer 43: 72–75, 1981 Hadjimichael O, Boyle C, Meigs J: Abortion before first live birth and risk of breast cancer. Br J Cancer 53: 281–284, 1986 Henderson IC: What can a woman do about her risk of dying of breast cancer? Curr Prob Cancer 14: 166–230, 1990 Miller D, Rosenberg L, Kaufman D: Breast cancer before age 45 and oral contraceptive use: New findings. Am J Epidemiol 129: 269–280, 1989 Bernstein L, Pike M, Krailo M, Henderson B: Update of the Los Angeles study of oral contraceptives and breast cancer. In: Mann R (ed) Oral Contraceptives and Breast Cancer. Parthenon Publishing Group, London, 1990, pp 169–172 Meirik O, Lund E, Adami H: Oral contraceptive use and breast cancer in young women. Lancet 2: 650–653, 1986 The Centers for Disease Control Cancer and Steroid Hormone Study: Long term oral contraceptive use and the risk of breast cancer. JAMA 259: 1591–1595, 1983 Morrow M: Pre-cancerous breast lesions: Implications for breast cancer prevention trials. Int J Rad Oncol Biol Phys 23: 1071–1078, 1992 Dupont W, Page D: Risk factors for breast cancer in women with proliferative disease. New Engl J Med 312: 146–151, 1985 Hutter R: Consensus meeting: Is ‘fibrocystic disease’ of the breast pre-cancerous? Arch Pathol Lab Med 110: 171–173, 1986 Morrow M: Management of nonpalpable breast masses. Updates to Principles and Practice of Oncology 4: 1–11, 1990 Rubin E, Visscher D, Alexander R, Urist M, Maddox WA: Proliferative disease and atypia in biopsies performed for nonpalpable lesions directed mammographically. Cancer 61: 2077–2082, 1988 Dupont W, Page D: Relative risk of breast cancer varies with time since diagnosis of atypical hyperplasia. Hum Pathol 20: 723–725, 1989 Andersen J: Lobular carcinomain situ of the breast. An approach to rational treatment. Cancer 39: 2597–2602, 1977 Haagensen C, Lane N, Lattes R, Bodian C: Lobular neoplasia (so called lobular carcinomain situ) of the breast. Cancer 42: 737–769, 1978 Rosen P, Lieberman P, Braun D, Kosloff C, Adair F: Lobular carcinomain situ of the breast. Am J Surg Path 2: 225–251, 1978 Rosai J: Borderline epithelial lesions of the breast. Am J Surg Path 15: 209–221, 1991 Seidman H, Mushinski M, Gelb S: Probability of eventually developing or dying of cancer, United States. CA-A Cancer Journal for Clinicians 35: 36–41, 1985 Morrow M: Breast disease in the elderly. Surgical Clinics of North America 74: 145–162, 1994 Tokunaga M, Land C, Yamamoto T: Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki 1950–1980. Rad Res 112: 243–272, 1987 Miller A, Howe G, Sherman G, Lindsay JP, Yaffe MJ, Dinner PJ, Risch HA, Preston DL: Mortality from breast cancer after irradiation during fluoroscopic examinations in patients being treated for tuberculosis. N Engl J Med 321: 1285–1289, 1989 Hildreth N, Shore L, Dvoretsky P: The risk of breast cancer after irradiation of the thymus in infancy. N Engl J Med 321: 146–151, 1989 Janjan NA, Zellmer DL: Calculated risk of breast cancer following mantle irradiation determined by measured dose. Cancer Detection Prevention 16: 273–282, 1992 Anderson D, Badzioch M: Combined effect of family history and reproductive factors on breast cancer risk. Cancer 63: 349–353, 1989 Brinton L, Hoover R, Fraumeni J: Interaction of familial and hormonal risk factors for breast cancer. J National Cancer Inst 69: 817–822, 1982 Gail M, Brinton L, Byar D, Cole DK, Green SB, Schairer C, Mulvihill JJ: Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J National Cancer Inst 81: 1879–1886, 1989 Foster RS, Costanza MC: Breast self exam practices and breast cancer survival. Cancer 53: 999–1005, 1984 Greenwald P, Nasca PC, Lawrence CE, Horton J, McGorrah RP, Gabrielle T, Carlton K: Estimated effect of breast self exam and routine physical exams on breast cancer mortality. N Engl J Med 299: 271–273, 1978 O'Malley MS, Fletcher SW: Screening for breast cancer with breast self examination. JAMA 257: 2196–2203, 1987 Laughter DC, Kean TJ, Drean KD, Esparza D, Hortobagyi G, Judkins A, Levitt DZ, Marcus C, Silberberg Y: The breast self examination practices of high risk women: Implications for patient education. Patient Counseling Health Education 3: 103–107, 1981 Stefanek MD, Wilcox P: Breast self examination among women at increased risk: Assessment of proficiency. Proc ASCO: p. 59, 1989 LaFrancis IE, Cooper RB: Second primary malignancies associated with primary female breast cancer: A review of the Danbury Hospital experience. Conn Med 56: 411–414, 1992 Shapiro S, Venet W, Strax P, Venet L: Periodic screening for breast cancer: The Health Insurance Plan Project and its sequelae. Johns Hopkins University Press, Baltimore, 1988 Tabar L, Fagerberg G, Duffy SW, Day NE: The Swedish two-county trial of mammographic screening for breast cancer: recent results and calculation of benefit. Epidemiol Comm Health 43: 107–114, 1989 Miller AB, Baines CJ, To T, Wall C: Canadian national breast screening study, 1:breast cancer detection and death rates among women aged 40 to 49 years. Can Med Asso J 147: 1459–1476, 1992 Meyer JE, Kopans DB, Oot R: Breast cancer visualized by mammography in patients under 35. Radiology 147: 93–94, 1983 Cohen MI, Mintzer R, Matthies HJ, Bernstein JR: Mammography in women less than 40 years of age. Surg Gynecol Obstet 160: 220–222, 1985 McSweeney MB, Egan RL: Breast cancer not just a disease of middle age. Diagn Imaging 1: 48–49, 1984 Woods J, Meland N: Conservative management of full thickness nipple areolar necrosis after subcutaneous mastectomy. Plast Reconstr Surg 84: 258–264, 1989 Pennisi V: Total mammary adenectomy with histologic evaluation and immediate reconstruction. Plast Reconstr Surg 68: 510–518, 1981 Goodnight JE, Quagliana JM, Morton DL: Failure of subcutaneous mastectomy to prevent the development of breast cancer. J Surg Oncol 26: 198–201, 1984 Goldman LD, Goldwyn RM: Some anatomical considerations of subcutaneous mastectomy. Plast Reconstr Surg 51: 501–505, 1973 Jackson C, Palmquist M, Swanson J: The effectiveness of prophylactic subcutaneous mastectomy in Sprague Dawley rats induced with 7,12 dimethylbenzanthracene. Plast Reconstr Surg 73: 249–260, 1984 Temple W, Lindsay R, Magi E, Urbanski S: Technical considerations for prophylactic mastectomy in patients at high risk for breast cancer. Am J Surg 161: 413–415, 1991 Morrow M, Jordan VC: Prospects for the prevention of breast cancer. Breast Diseases Updates 2: 1–12, 1992 Morrow M, Jordan VC: The tamoxifen trial for breast cancer: clinical issues. Cancer Prevention 1-10, 1992 Jordan VC, Morrow M: An appraisal of strategies to reduce the incidence of breast cancer. Stem Cells 11: 252–262, 1993